Clinical trials
Phase 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 3 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Unknown status | 6 |
| Terminated | 4 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 13 |
| Cttq | 1 |
| Dong-A ST Co., Ltd. | 1 |
| Dong-Wook Kim | 1 |
| Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | 1 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 1 |
| Hospital Universitario Dr. Jose E. Gonzalez | 1 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | 1 |
| King Abdullah International Medical Research Center | 1 |
| PETHEMA Foundation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 29 |
| Leukemia | 4 |
| Blast Crisis | 2 |
| Bronchiolitis Obliterans Syndrome | 2 |
| Gastrointestinal Stromal Tumors | 2 |
| Chromosome Aberrations | 1 |
| Dwarfism | 1 |
| Leukemia, Myeloid, Chronic-Phase | 1 |
| Myeloproliferative Disorders | 1 |
| Philadelphia Chromosome | 1 |
Trials
Showing 26 to 29 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.